Plain-English translation of NCT07029555 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing a new medication called for rheumatoid arthritis. The study will give participants increasing doses of the medication as an injection under the skin to see how safe it is and how the body responds to it. Researchers want to find the right dose that works well without causing serious side effects.
Rheumatoid arthritis affects many people and current treatments don't work equally well for everyone. This research is exploring whether this new treatment might offer another option for people living with this condition.
You will receive injections of the medication under your skin, starting with a low dose and gradually increasing to higher doses as the study progresses. Everyone in the study knows they are receiving the new treatment (this is called an open-label study). The study will monitor your safety carefully through visits and tests to make sure the medication is working safely at each dose level.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Argentina
Bulgaria
China